NAD+ and vitamin B3: from metabolism to therapies - PubMed (original) (raw)
Review
. 2008 Mar;324(3):883-93.
doi: 10.1124/jpet.107.120758. Epub 2007 Dec 28.
Affiliations
- PMID: 18165311
- DOI: 10.1124/jpet.107.120758
Review
NAD+ and vitamin B3: from metabolism to therapies
Anthony A Sauve. J Pharmacol Exp Ther. 2008 Mar.
Abstract
The role of NAD(+) metabolism in health and disease is of increased interest as the use of niacin (nicotinic acid) has emerged as a major therapy for treatment of hyperlipidemias and with the recognition that nicotinamide can protect tissues and NAD(+) metabolism in a variety of disease states, including ischemia/reperfusion. In addition, a growing body of evidence supports the view that NAD(+) metabolism regulates important biological effects, including lifespan. NAD(+) exerts potent effects through the poly(ADP-ribose) polymerases, mono-ADP-ribosyltransferases, and the recently characterized sirtuin enzymes. These enzymes catalyze protein modifications, such as ADP-ribosylation and deacetylation, leading to changes in protein function. These enzymes regulate apoptosis, DNA repair, stress resistance, metabolism, and endocrine signaling, suggesting that these enzymes and/or NAD(+) metabolism could be targeted for therapeutic benefit. This review considers current knowledge of NAD(+) metabolism in humans and microbes, including new insights into mechanisms that regulate NAD(+) biosynthetic pathways, current use of nicotinamide and nicotinic acid as pharmacological agents, and opportunities for drug design that are directed at modulation of NAD(+) biosynthesis for treatment of human disorders and infections.
Similar articles
- Vitamin B3, the nicotinamide adenine dinucleotides and aging.
Xu P, Sauve AA. Xu P, et al. Mech Ageing Dev. 2010 Apr;131(4):287-98. doi: 10.1016/j.mad.2010.03.006. Epub 2010 Mar 20. Mech Ageing Dev. 2010. PMID: 20307564 Review. - NAD+ metabolism in health and disease.
Belenky P, Bogan KL, Brenner C. Belenky P, et al. Trends Biochem Sci. 2007 Jan;32(1):12-9. doi: 10.1016/j.tibs.2006.11.006. Epub 2006 Dec 11. Trends Biochem Sci. 2007. PMID: 17161604 Review. - Niacin and carcinogenesis.
Kirkland JB. Kirkland JB. Nutr Cancer. 2003;46(2):110-8. doi: 10.1207/S15327914NC4602_02. Nutr Cancer. 2003. PMID: 14690785 Review. - The NAD+ precursors, nicotinic acid and nicotinamide protect cells against apoptosis induced by a multiple stress inducer, deoxycholate.
Crowley CL, Payne CM, Bernstein H, Bernstein C, Roe D. Crowley CL, et al. Cell Death Differ. 2000 Mar;7(3):314-26. doi: 10.1038/sj.cdd.4400658. Cell Death Differ. 2000. PMID: 10745276 - Vitamin B3 in Health and Disease: Toward the Second Century of Discovery.
Jacobson MK, Jacobson EL. Jacobson MK, et al. Methods Mol Biol. 2018;1813:3-8. doi: 10.1007/978-1-4939-8588-3_1. Methods Mol Biol. 2018. PMID: 30097857 Review.
Cited by
- Determination of niacin profiles in some animal and plant based foods by high performance liquid chromatography: association with healthy nutrition.
Çatak J. Çatak J. J Anim Sci Technol. 2019 May;61(3):138-146. doi: 10.5187/jast.2019.61.3.138. Epub 2019 May 31. J Anim Sci Technol. 2019. PMID: 31333870 Free PMC article. - Scalable syntheses of traceable ribosylated NAD+ precursors.
Makarov MV, Harris NW, Rodrigues M, Migaud ME. Makarov MV, et al. Org Biomol Chem. 2019 Oct 14;17(38):8716-8720. doi: 10.1039/c9ob01981b. Epub 2019 Sep 20. Org Biomol Chem. 2019. PMID: 31538639 Free PMC article. - Muscle type-specific responses to NAD+ salvage biosynthesis promote muscle function in Caenorhabditis elegans.
Vrablik TL, Wang W, Upadhyay A, Hanna-Rose W. Vrablik TL, et al. Dev Biol. 2011 Jan 15;349(2):387-94. doi: 10.1016/j.ydbio.2010.11.014. Epub 2010 Nov 16. Dev Biol. 2011. PMID: 21092737 Free PMC article. - Implications of altered NAD metabolism in metabolic disorders.
Okabe K, Yaku K, Tobe K, Nakagawa T. Okabe K, et al. J Biomed Sci. 2019 May 11;26(1):34. doi: 10.1186/s12929-019-0527-8. J Biomed Sci. 2019. PMID: 31078136 Free PMC article. Review. - Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule.
Elhassan YS, Philp AA, Lavery GG. Elhassan YS, et al. J Endocr Soc. 2017 May 15;1(7):816-835. doi: 10.1210/js.2017-00092. eCollection 2017 Jul 1. J Endocr Soc. 2017. PMID: 29264533 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources